Entry |
|
Name |
Delanzomib (USAN) |
Formula |
C21H28BN3O5
|
Exact mass |
413.2122
|
Mol weight |
413.2751
|
Structure |
|
Class |
Antineoplastic
DG03134 Proteasome inhibitor
|
Efficacy |
Antineoplastic, Proteasome inhibitor |
Comment |
Treatment of multiple myeloma, mantel cell lymphoma
|
Target |
|
Pathway |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG03134 Proteasome inhibitor
D10110 Delanzomib
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Threonine peptidases
PSMB1
D10110 Delanzomib (USAN)
PSMB5
D10110 Delanzomib (USAN)
|
Other DBs |
|
KCF data |
ATOM 30
1 C8y C 13.8491 -16.5169
2 C8x C 13.8491 -17.9221
3 C8x C 15.0660 -18.6247
4 C8x C 16.2830 -17.9221
5 C8y C 16.2830 -16.5169
6 N5x N 15.0660 -15.8143
7 C8y C 12.6321 -15.8143
8 C8x C 12.6321 -14.4093
9 C8x C 11.4151 -13.7067
10 C8x C 10.1982 -14.4093
11 C8x C 10.1982 -15.8143
12 C8x C 11.4151 -16.5169
13 C5a C 17.5187 -15.8032
14 N1b N 18.7284 -16.5015
15 O5a O 17.5184 -14.4092
16 C1c C 19.9151 -15.8162
17 C5a C 21.1136 -16.5081
18 N1b N 22.3059 -15.8195
19 O5a O 21.1138 -17.9218
20 C1c C 19.9151 -14.4093
21 O1a O 18.6805 -13.6963
22 C1a C 21.1144 -13.7167
23 C1c C 23.5015 -16.5098
24 C1b C 24.6953 -15.8204
25 Z B 23.5017 -17.9218
26 O1a O 24.6985 -18.6130
27 O1a O 22.2647 -18.6364
28 C1c C 25.8901 -16.5103
29 C1a C 27.0844 -15.8206
30 C1a C 25.8903 -17.9219
BOND 31
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 11 12 2
13 7 12 1
14 5 13 1
15 13 14 1
16 13 15 2
17 16 14 1 #Up
18 16 17 1
19 17 18 1
20 17 19 2
21 16 20 1
22 20 21 1 #Down
23 20 22 1
24 18 23 1
25 23 24 1
26 23 25 1 #Up
27 25 26 1
28 25 27 1
29 24 28 1
30 28 29 1
31 28 30 1
|